On 23 February 2018
SMS Lifesciences India will hold a meeting of the Board of Directors of the Company on 23 February 2018, to consider the Due Diligence Report on Acquisition of M/s Mahi Drugs Private Limited, an API manufacturing company and other related matters thereon.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
